English

Pharmaceutical companies

Economy

The Ozempic ripple: When a single jab moves an entire market

ADVERTISEMENT

ADVERTISEMENT

More about this topic

Healthcare

Eli Lilly hikes UK price of blockbuster weight loss drug Mounjaro

The price hike is not expected to affect access for patients who receive Mounjaro through the National Health Service (NHS).

Health news

Experimental pill helped with weight loss in Eli Lilly trial

Study participants lost an average of 12.4 per cent of their body weight over 72 weeks.

Markets

Pfizer earnings strong despite Trump’s new 'up to 250%' tariff threat

Pfizer beat earnings expectations and improved its outlook for the rest of the year, despite fresh statements from Trump announcing pharma tariffs next week.

Health news

EU-US trade deal leaves future of pharma tariffs uncertain

Despite a new EU-US trade deal, tariffs on pharmaceuticals remain uncertain and unchanged for now, pending the outcome of a US national security investigation that could later impose duties of up to 15%.

ADVERTISEMENT

Business

AstraZeneca pledges $50bn investment in the US amid 200% tariff fears

British-Swedish pharmaceutical company AstraZeneca is expanding its presence in the US in a bid to boost sales in its largest market.

Economy

President Trump: Pharma tariff is coming, Indonesia deal sealed

The US President announced a list of updates concerning US trade tariffs on Tuesday, including a deal with Indonesia and his plans to gradually increase tariffs on pharmaceutical imports.

Markets

EU pharma chief calls for European Nasdaq to boost biotech innovation

The head of the EU's pharmaceutical lobby has called for the creation of a life sciences-focused stock market in Europe, modelled after the US Nasdaq, to help retain biotech innovation and investment within the region.

Business Line

Uzbekistan expands pharma production with €1.2bn investment

In partnership with Agency of Information and Mass Communications of Uzbekistan

Uzbekistan is rapidly scaling up its pharmaceutical sector with the launch of Tashkent Pharma Park — a €1.2 billion project uniting research, logistics, manufacturing and training.

Health news

Meet the company leveraging AI-backed physics tools for drug discovery

The start-up aims to use AI to drastically reduce the time and money it takes to develop new drugs.

Health news

Novo Nordisk CEO steps down amid competition for weight loss drugs

Lars Fruergaard Jørgensen, who has led the pharmaceutical giant since 2017, joined the firm in 1991.

Healthcare

Which countries in Europe pay the most for medicines?

Europeans pay different prices for medicines based on where exactly they live, but they spend way less than the US does.

Business

Bayer shares soar as company records strong cancer drug demand

Bayer’s strong first quarter performance was mainly driven by its pharmaceuticals division, even as its crop-science branch lagged.

Business

Novo Nordisk cuts forecast as weight-loss drug competition heats up

Novo Nordisk shares jumped following stronger-than-expected first-quarter earnings, despite the company lowering its growth outlook for 2025 amid intensifying competition in the weight-loss drug markets.

Health news

EU holds firm on pharma reform proposal despite industry pressure

The European Commission has no plans to withdraw or revise its proposed overhaul of EU pharmaceutical rules, despite mounting pressure from the pharmaceutical industry concerned about potential tariffs and the sector’s competitiveness.

Health news

Tariff treatment: Six diagnoses for EU pharma sector amid US trade war

Potential US tariffs on pharmaceuticals could set off a ripple effect that extends far beyond the immediate price hikes, as both the US and Europe heavily rely on each other.

Europe News

Who should pay for urban wastewater treatment?

The pharmaceutical and cosmetics industries have gone to the EU's court to challenge a directive that requires them to finance at least 80% of urban wastewater treatment.

Business

Bayer ordered to pay €1.9 billion by US court in Roundup cancer case

Pharmaceutical company Bayer took over weed killer Roundup in its acquisition of US agrochemical company Monsanto back in 2018. However, it has since been hit with thousands of cancer-related Roundup cases.

Health news

5 takeaways on the Critical Medicines Act

From funding challenges to what changes in joint drug procurement: Here’s what you need to know about the new rules aimed at securing Europe's access to critical medicines.

Economy

Here’s why Trump’s tariffs could hit Ireland’s pharma sector hardest

The Irish economy is particularly vulnerable to US tariffs against the EU, as it exports relatively more to the US compared to other EU economies.

Health news

Big pharma urges Commission to slow down new critical medicines rules

With the date of publication for a Critical Medicines Act fast approaching, the EU’s pharma industry is urging the Commission to slow down rather than keeping to a promise made by Health Commissioner Oliver Várhelyi to launch the proposal within the first 100 days of his mandate.